사이토카인 방출 증후군 등의 개선제

(과제) 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증, 또는 랑게르한스 세포 조직구증에 대한 의약의 제공. (해결 수단) 다음 식 I : 로 나타내는 화합물, 또는 그 약학적으로 허용되는 염을 포함하는, 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증 및 랑게르한스 세포 조직구증으로 이루어지는 군에서 선택되는 적어도 1 개에 대한 의약.] TIFFpct00019.tif5195 [Problem to be Sol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TAHARA YOSHIO, OHMAE SAORI, WATANABE YOSHIHIRO, SUZUKI KEISUKE, MIMURA TAKAYUKI
Format:	Patent
Sprache:	kor
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	TAHARA YOSHIO OHMAE SAORI WATANABE YOSHIHIRO SUZUKI KEISUKE MIMURA TAKAYUKI
description	(과제) 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증, 또는 랑게르한스 세포 조직구증에 대한 의약의 제공. (해결 수단) 다음 식 I : 로 나타내는 화합물, 또는 그 약학적으로 허용되는 염을 포함하는, 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증 및 랑게르한스 세포 조직구증으로 이루어지는 군에서 선택되는 적어도 1 개에 대한 의약.] TIFFpct00019.tif5195 [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis.[Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I:or a pharmaceutically acceptable salt thereof.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20200130865A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20200130865A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20200130865A3</originalsourceid><addsrcrecordid>eNrjZDB807Tmzdwtb9sWvNm55c3cHQqvN6x8s22Owptlc9_Obnm1dYPC68kb38ydofBqw5w3LQveLJjDw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvivYOMDIwMDAyNDSzMTB2NiVMFAA1MOzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>사이토카인 방출 증후군 등의 개선제</title><source>esp@cenet</source><creator>TAHARA YOSHIO ; OHMAE SAORI ; WATANABE YOSHIHIRO ; SUZUKI KEISUKE ; MIMURA TAKAYUKI</creator><creatorcontrib>TAHARA YOSHIO ; OHMAE SAORI ; WATANABE YOSHIHIRO ; SUZUKI KEISUKE ; MIMURA TAKAYUKI</creatorcontrib><description>(과제) 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증, 또는 랑게르한스 세포 조직구증에 대한 의약의 제공. (해결 수단) 다음 식 I : 로 나타내는 화합물, 또는 그 약학적으로 허용되는 염을 포함하는, 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증 및 랑게르한스 세포 조직구증으로 이루어지는 군에서 선택되는 적어도 1 개에 대한 의약.] TIFFpct00019.tif5195 [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis.[Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I:or a pharmaceutically acceptable salt thereof.</description><language>kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201120&DB=EPODOC&CC=KR&NR=20200130865A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201120&DB=EPODOC&CC=KR&NR=20200130865A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAHARA YOSHIO</creatorcontrib><creatorcontrib>OHMAE SAORI</creatorcontrib><creatorcontrib>WATANABE YOSHIHIRO</creatorcontrib><creatorcontrib>SUZUKI KEISUKE</creatorcontrib><creatorcontrib>MIMURA TAKAYUKI</creatorcontrib><title>사이토카인 방출 증후군 등의 개선제</title><description>(과제) 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증, 또는 랑게르한스 세포 조직구증에 대한 의약의 제공. (해결 수단) 다음 식 I : 로 나타내는 화합물, 또는 그 약학적으로 허용되는 염을 포함하는, 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증 및 랑게르한스 세포 조직구증으로 이루어지는 군에서 선택되는 적어도 1 개에 대한 의약.] TIFFpct00019.tif5195 [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis.[Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I:or a pharmaceutically acceptable salt thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB807Tmzdwtb9sWvNm55c3cHQqvN6x8s22Owptlc9_Obnm1dYPC68kb38ydofBqw5w3LQveLJjDw8CalphTnMoLpbkZlN1cQ5w9dFML8uNTiwsSk1PzUkvivYOMDIwMDAyNDSzMTB2NiVMFAA1MOzg</recordid><startdate>20201120</startdate><enddate>20201120</enddate><creator>TAHARA YOSHIO</creator><creator>OHMAE SAORI</creator><creator>WATANABE YOSHIHIRO</creator><creator>SUZUKI KEISUKE</creator><creator>MIMURA TAKAYUKI</creator><scope>EVB</scope></search><sort><creationdate>20201120</creationdate><title>사이토카인 방출 증후군 등의 개선제</title><author>TAHARA YOSHIO ; OHMAE SAORI ; WATANABE YOSHIHIRO ; SUZUKI KEISUKE ; MIMURA TAKAYUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20200130865A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAHARA YOSHIO</creatorcontrib><creatorcontrib>OHMAE SAORI</creatorcontrib><creatorcontrib>WATANABE YOSHIHIRO</creatorcontrib><creatorcontrib>SUZUKI KEISUKE</creatorcontrib><creatorcontrib>MIMURA TAKAYUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAHARA YOSHIO</au><au>OHMAE SAORI</au><au>WATANABE YOSHIHIRO</au><au>SUZUKI KEISUKE</au><au>MIMURA TAKAYUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>사이토카인 방출 증후군 등의 개선제</title><date>2020-11-20</date><risdate>2020</risdate><abstract>(과제) 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증, 또는 랑게르한스 세포 조직구증에 대한 의약의 제공. (해결 수단) 다음 식 I : 로 나타내는 화합물, 또는 그 약학적으로 허용되는 염을 포함하는, 사이토카인 방출 증후군, 자기 면역 질환 관련 부작용, 마크로파지 활성화 증후군, 혈구 탐식성 림프 조직구증 및 랑게르한스 세포 조직구증으로 이루어지는 군에서 선택되는 적어도 1 개에 대한 의약.] TIFFpct00019.tif5195 [Problem to be Solved] The present invention provides a medicament for cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis or Langerhans cell histiocytosis.[Means to Solve the Problem] The present invention provides a medicament for at least one selected from the group consisting of cytokine release syndrome, autoimmune-related adverse events, macrophage activation syndrome, hemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis, wherein the medicament comprises a compound represented by the following formula I:or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	kor
recordid	cdi_epo_espacenet_KR20200130865A
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	사이토카인 방출 증후군 등의 개선제
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A04%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAHARA%20YOSHIO&rft.date=2020-11-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20200130865A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true